SHARE THIS PAGE:
Lyme disease is a bacterial disease which in the US is caused by the bacteria Borrelia burgdorferi or newly discovered Borrelia mayonii. The bacteria can attack all of the systems in the body and produce many different Lyme disease symptoms, which is why it has often been called the great imitator. Women with Lyme disease who are pregnant or are thinking of becoming pregnant need to receive appropriate care from a knowledgeable Lyme disease doctor. Information on Lyme and pregnancy can be found in this section. Guidelines which help doctors with Lyme treatment have been developed and some can be found here, as well as various photos and videos pertaining to Lyme disease bacteria.
Frontiers in Medicine (Adkison, H. and Embers, M.) published a review article 5.24.23 “Lyme disease and the pursuit of a clinical cure.” This review focuses on the various mechanisms that […]
According to the Market Watch article published 4.11.23, Moderna Inc. announced it is working to develop its first bacterial vaccine to protect against Lyme disease. This news was announced at […]
According to a Propublica, non-profit newsroom, article by Patrick Rucker, Maya Miller and David Armstrong, 3.25.23, Cigna health insurance doctors are routinely rejecting patients’ claims for medical care, without ever […]
The Nantucker CURRENT (Graziadei, J.) 2.18.23, reported that Pfizer has shut down its Lyme disease vaccine trial site in Nantucket. Pfizer informed all Lyme disease vaccine clinical trial participants that the site was shut down “following potential violations of Good Clinical Practice (GCP) at clinical trial sites operated by a third party.”
Evan M. Bloch, et al., published “Comparing the Epidemiology and Health Burden of Lyme Disease and Babesiosis Hospitalizations in the United States” in the November 2022 issue of Open Forum Infectious Diseases which provides the results of a study that examined a nationally representative sample of patient hospitalizations.
ContagionLive published the article “Lyme Disease Vaccine Shows Antibodies 6 Months after Completion” by Senior Editor, John Parkinson, on December 1, 2022. The article provides details of the most recent investigational outcomes for Pfizer and Valneva’s Lyme disease vaccine candidate, VLA15.
Arick P.Sabin, et al., published “Clinical evaluation of a Borrelia modified two-tiered testing (MTTT) shows increased early sensitivity for Borrelia burgdorferi but not other endemic Borrelia species in a high incidence region for Lyme disease in Wisconsin” in Diagnostic Microbiology and Infectious Disease on November 9, 2022,* (version of record). Recently, a modified two-tiered testing algorithm (MTTT; ZEUS Scientific) for Borrelia burgdorferi was cleared by the FDA. This led the researchers to assess the algorithm to verify Lyme disease as well as evaluate the results in comparison to those acquired using standard two-tiered testing (STTT).
As reported on WDRB.com on November 9, 2022, from Tarsus Pharmaceuticals, Inc, (GLOBAl NEWSWIRE), Tarsus “is developing TP-05, an oral, non-vaccine therapeutic for the prevention of Lyme disease, which is currently being studied in a Phase 1b clinical trial.”
Valneva, a specialty vaccine company, announced its intent to issue and sell shares of the company through a news release “Global Offering of American Depositary Shares and Ordinary Shares” released […]
Tulane News, (Tate, L.) published “Tulane researchers to develop new Lyme vaccine with lasting protection” on September 28, 2022. Tulane University researchers received National Institutes of Health (NIH) funding in […]
LDA Doctor Referral System © Terms & Conditions and Guidelines
Save this Information for Your Records:
About LDA DOCTOR REFERRAL SYSTEM ©
Welcome to the Lyme Disease Association’s LDA Doctor Referral System ©. LDA made updates and enhancements to its prior system and has launched a new site to provide patients with information about doctors, other practitioners, testing labs, and pharmacies that are knowledgeable about chronic Lyme disease and often about many other tick-borne diseases (TBD). Many of the doctors listed are often referred to as Lyme Literate Physicians/Doctors (LLMD). Tens of thousands of patients have successfully used the prior LDA system to locate Lyme and TBD resources.
Terms & Conditions and Guidelines
Because there is a negative political climate surrounding Lyme disease, many LLMDs do not want their names posted outright on the internet. LDA has tried to balance the doctors’ wishes with patients’ need to find a doctor. This new system is a result of that compromise and therefore:
Because of the limited number of physicians treating chronic Lyme disease nationwide, some states, and in some instances, entire regions, may not have any treating physicians who follow flexible treating approaches such as those in the International Lyme & Associated Diseases Society (ILADS) Guidelines, Evidence Assessments and Guideline Recommendations in Lyme Disease: The Clinical Management of Known Tick Bites, Erythema Migrans Rashes and Persistent Disease. In the event that the LDA Doctor Referral System © contains no Lyme or TBD resource listings in a given area, the closest possible option(s) will populate based on the location entered and specaialty/ies selected. The LDA appreciates any changes in provider information that you may find and make us aware of so we can investigate.